Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -207.84 | N/A |
| PEG Ratio (TTM) | 1.04 | N/A |
| P/S Ratio (TTM) | 0.93 | N/A |
| P/B Ratio (TTM) | 5.31 | N/A |
| P/FCF Ratio (TTM) | 3.91 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | 4.42 | N/A |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.02% | N/A |
| ROE (TTM) | -2.46% | N/A |
| Net Profit Margin (TTM) | -8.90% | N/A |
| ROIC 5YR AVG | 2.30% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 16.66% | 26.00% | 5.58% |
| Revenue | -4.34% | 39.74% | 43.61% |
| Net Income | 34.13% | 24.32% | 21.20% |
| Cash Flow | -3.53% | 72.87% | 61.07% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 139.31 | N/A |
| Quick Ratio (TTM) | 139.31 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 3.26 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.15 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | 1,939,293,778.47% | N/A |